AQR Capital Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.1K | Buy |
80,624
+22,401
| +38% | +$25.3K | ﹤0.01% | 3196 |
|
|
2025
Q1 | $85K | Buy |
+58,223
| New | +$85K | ﹤0.01% | 3039 |
|
|
2024
Q4 | – | Sell |
-33,589
| Closed | -$94.1K | – | 2865 |
|
|
2024
Q3 | $94.1K | Buy |
33,589
+6,302
| +23% | +$17.6K | ﹤0.01% | 2661 |
|
|
2024
Q2 | $63.6K | Buy |
+27,287
| New | +$63.6K | ﹤0.01% | 2530 |
|
|
2022
Q2 | – | Sell |
-73,717
| Closed | -$672K | – | 2175 |
|
|
2022
Q1 | $672K | Buy |
73,717
+44,832
| +155% | +$409K | ﹤0.01% | 1702 |
|
|
2021
Q4 | $431K | Buy |
28,885
+8,591
| +42% | +$128K | ﹤0.01% | 1869 |
|
|
2021
Q3 | $522K | Sell |
20,294
-16,423
| -45% | -$422K | ﹤0.01% | 1852 |
|
|
2021
Q2 | $958K | Buy |
+36,717
| New | +$958K | ﹤0.01% | 1611 |
|
|
2020
Q4 | – | Sell |
-8,576
| Closed | -$323K | – | 2179 |
|
|
2020
Q3 | $323K | Buy |
+8,576
| New | +$323K | ﹤0.01% | 1883 |
|